AR090624A1 - Proteinas de la membrana exterior de histophilus somni y sus metodos - Google Patents

Proteinas de la membrana exterior de histophilus somni y sus metodos

Info

Publication number
AR090624A1
AR090624A1 ARP130101126A ARP130101126A AR090624A1 AR 090624 A1 AR090624 A1 AR 090624A1 AR P130101126 A ARP130101126 A AR P130101126A AR P130101126 A ARP130101126 A AR P130101126A AR 090624 A1 AR090624 A1 AR 090624A1
Authority
AR
Argentina
Prior art keywords
methods
proteins
external membrane
histophilus somni
somni
Prior art date
Application number
ARP130101126A
Other languages
English (en)
Inventor
P Knittel Jeffrey
Dean Lilly Brice
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of AR090624A1 publication Critical patent/AR090624A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza

Abstract

Composiciones inmunológicas de proteínas de la membrana exterior (OMP) de H. somni, así como también métodos de extracción, un modelo para la exposición respiratoria, métodos de administración y ensayos y kits de diagnóstico.
ARP130101126A 2012-04-05 2013-04-05 Proteinas de la membrana exterior de histophilus somni y sus metodos AR090624A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261620652P 2012-04-05 2012-04-05

Publications (1)

Publication Number Publication Date
AR090624A1 true AR090624A1 (es) 2014-11-26

Family

ID=49292471

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP130101114A AR090613A1 (es) 2012-04-05 2013-04-04 Proteinas de la membrana exterior de histophilus somni y sus metodos
ARP130101126A AR090624A1 (es) 2012-04-05 2013-04-05 Proteinas de la membrana exterior de histophilus somni y sus metodos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP130101114A AR090613A1 (es) 2012-04-05 2013-04-04 Proteinas de la membrana exterior de histophilus somni y sus metodos

Country Status (17)

Country Link
US (1) US9597386B2 (es)
EP (1) EP2833912A1 (es)
JP (1) JP2015519305A (es)
KR (1) KR20150003269A (es)
CN (1) CN104470539A (es)
AR (2) AR090613A1 (es)
AU (1) AU2013243622A1 (es)
BR (1) BR112014024491A2 (es)
CA (1) CA2866888A1 (es)
CL (1) CL2014002658A1 (es)
CO (1) CO7160028A2 (es)
EA (1) EA201401078A1 (es)
MX (1) MX2014012013A (es)
PH (1) PH12014502223A1 (es)
SG (1) SG11201406209WA (es)
UY (1) UY34733A (es)
WO (1) WO2013151979A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013069832A1 (ko) * 2011-11-10 2013-05-16 주식회사 독도 발열용기
US9597386B2 (en) 2012-04-05 2017-03-21 Boehringer Ingelheim Vetmedica, Inc. Outer membrane proteins of Histophilus somni and methods thereof
WO2015118111A2 (en) * 2014-02-07 2015-08-13 Basf Se Modified microorganism with improved biomass separation behaviour
CA2943786C (en) * 2014-03-25 2023-12-12 Merial, Inc. Immunological compositions containing attenuated histophilus somni
KR101960016B1 (ko) * 2018-04-09 2019-07-15 전북대학교 산학협력단 호흡기 질병의 원인체를 검출하기 위한 조성물 및 이를 이용한 방법
KR101960017B1 (ko) * 2018-04-09 2019-07-15 전북대학교 산학협력단 호흡기 질병의 원인체를 검출하기 위한 조성물 및 이를 이용한 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
EP0635055B1 (en) 1992-04-09 1998-12-23 The University of Saskatchewan Haemophilus somnus immunogenic proteins
US6100066A (en) 1992-04-09 2000-08-08 University Of Saskatchewan Nucleic acid molecules encoding Haemophilus somnus proteins
US5534256A (en) 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
CA2347278C (en) 1998-09-25 2007-07-17 Lynette B. Corbeil Vaccine based on attenuated haemophilus somnus
JP2004222593A (ja) * 2003-01-23 2004-08-12 National Agriculture & Bio-Oriented Research Organization 反芻獣病原細菌の主要外膜タンパク質をコードする遺伝子
US9597386B2 (en) 2012-04-05 2017-03-21 Boehringer Ingelheim Vetmedica, Inc. Outer membrane proteins of Histophilus somni and methods thereof

Also Published As

Publication number Publication date
CN104470539A (zh) 2015-03-25
UY34733A (es) 2013-10-31
AR090613A1 (es) 2014-11-26
EP2833912A1 (en) 2015-02-11
SG11201406209WA (en) 2014-10-30
CA2866888A1 (en) 2013-10-10
MX2014012013A (es) 2014-11-25
CL2014002658A1 (es) 2015-03-20
EA201401078A1 (ru) 2015-04-30
KR20150003269A (ko) 2015-01-08
BR112014024491A2 (pt) 2017-08-08
JP2015519305A (ja) 2015-07-09
US20130266613A1 (en) 2013-10-10
PH12014502223A1 (en) 2015-01-12
CO7160028A2 (es) 2015-01-15
AU2013243622A1 (en) 2014-09-25
WO2013151979A1 (en) 2013-10-10
US9597386B2 (en) 2017-03-21

Similar Documents

Publication Publication Date Title
AR090624A1 (es) Proteinas de la membrana exterior de histophilus somni y sus metodos
CL2016003109A1 (es) Una máscara de ventilación de gas, que comprende una máscara nasal y una máscara bucal, conectadas de manera separable entre sí, en la que unas cámaras nasal y oral están conectadas entre sí a través de un tabique de cierre automático o válvula.
BR112018008102A2 (pt) vacina de vírus sincicial respiratório
UY34697A (es) Métodos para preparar análogos de nucleótidos
DK2984209T3 (da) Fremgangsmåder til fremstilling af en brændbar gas ud fra elektrolyse af vand (eht) eller co-elektrolyse med h2o/co2 i samme indelukke, dertil hørende katalytisk reaktor og system
BR112016012129A8 (pt) métodos para produção, expansão e purificação de células epiteliais do pigmento da retina, composição farmacêutica e uso das células
NI201400079A (es) Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
NI201400080A (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
AR103077A1 (es) Método para la producción de un sistema de administración farmacéutica
BR112017012210A2 (pt) solução conservante de célula, uso da mesma e método de produção de solução conservante de célula
BR112014013786A8 (pt) método para ventilação de um indivíduo, método para rapidamente ventilar um indivíduo que apresenta desconforto respiratório, e, dispositivo para ventilação de um indivíduo através de uma ou mais passagens do corpo
TWD170487S (zh) 喉罩氣道
BR112012022090A2 (pt) utilização de ácido elágico como agente anticaspa
DK3580567T3 (da) I vitro-fremgangsmåde til diagnose af lungkræft
DK3084442T3 (da) Diagnostiske reagenser til forbedret in vivo eller in vitro cellemedieret immunologisk diagnosticering af tuberkulose
AR101254A1 (es) Instrumentos quirúrgicos de tomografía de coherencia óptica aumentados y sistemas y métodos para corregir movimientos no deseados de instrumentos quirúrgicos
CL2019002831A1 (es) Dispositivos y sistemas de difusión microfluídica, y métodos de fabricación y uso
FR3015594B1 (fr) Compresseur de turbomachine, en particulier de turbopropulseur ou de turboreacteur d'avion
BR112014027680A2 (pt) ventilador, método para estimar uma fração de oxigênio inalado durante a provisão de ventilação a um sujeito, e sistema configurado para prover ventilação a um sujeito
BR112015004494A2 (pt) célula de fluxo de permeabilidade e sistema de condutância hidráulica
BR112015027977A2 (pt) método para a produção de formulações de óleo, formulações de óleo, e uso das formulações de óleo
RU2011133480A (ru) Средство, обладающее ритмомодулирующим действием
UY34128A (es) Métodos, composiciones y kits para determinar el virus de la inmunodeficiencia humana (vih)?.
BR112017027304A2 (pt) método para o diagnóstico de doença de farber
BR112015004430A2 (pt) célula de fluxo de permeabilidade e sistema de condutância hidráulica

Legal Events

Date Code Title Description
FB Suspension of granting procedure